Effect of HMR 3339, a novel selective estrogen receptor modulator, on C-reactive protein levels in healthy postmenopausal women

被引：10
|
作者：
Vogelvang, TE
Mijatovic, V
Kenemans, P
Schalkwijk, CG
van der Mooren, MJ
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Dept Obstet & Gynecol, ICaR, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, ICaR, NL-1007 MB Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Project Aging Women, NL-1007 MB Amsterdam, Netherlands
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 09期
关键词：
D O I：
10.1016/j.amjcard.2004.07.099
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We investigated the 12-week effects of 3 doses of HMR 3339, a novel selective estrogen receptor modulator, in comparison with raloxifene and placebo, on plasma concentrations of C-reactive protein in 96 healthy postmenopausal women. A dose-dependent reduction in C-reactive protein was observed, the largest reduction with HMR 3339 50 mg. (C) 2004 by Excerpta Medica, Inc.
引用
收藏
页码：1205 / 1208
页数：4
相关论文
共 50 条
  • [41] Effects of Hormone Replacement Therapy on Serum Homocysteine and C-Reactive Protein Levels in Postmenopausal Women
    Kiran, Hakan
    Kiran, Gurkan
    Cetin, M. Turan
    JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2006, 7 (01) : 18 - 23
  • [42] Short-term effect of tibolone on C-reactive protein in hypertensive postmenopausal women
    Yaprak Engin-Üstün
    Yusuf Üstün
    Ilgın Türkçüoğlu
    M. Mutlu Meydanlı
    Ayşe Kafkaslı
    Gülay Yetkin
    Archives of Gynecology and Obstetrics, 2009, 279 : 305 - 309
  • [43] Effect of soy nuts on C-reactive protein and soluble adhesion molecules postmenopausal women
    Welty, FK
    Lee, KS
    CIRCULATION, 2004, 110 (17) : 778 - 778
  • [44] Effect of tamoxifen at low doses on ultrasensitive C-reactive protein in healthy women
    Bonanni, B
    Johansson, H
    Gandini, S
    Guerrieri-Gonzaga, A
    Sandri, MT
    Mariette, F
    Lien, EA
    Decensi, A
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (10) : 2149 - 2152
  • [45] Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
    Gennari, Luigi
    Merlotti, Daniela
    Nuti, Ranuccio
    CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 19 - 29
  • [46] Bazedoxifene: An investigational selective estrogen receptor modulator for the treatment and prevention of osteoporosis in postmenopausal women
    Sobieraj, Diana M.
    Nigro, Stefanie C.
    FORMULARY, 2011, 46 (05) : 159 - +
  • [47] Short-term effect of tibolone on C-reactive protein in hypertensive postmenopausal women
    Engin-Uestuen, Yaprak
    Uestuen, Yusuf
    Tuerkcueoglu, Ilgin
    Meydanli, M. Mutlu
    Kafkasgh, Ayse
    Yetkin, Guelay
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2009, 279 (03) : 305 - 309
  • [48] Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women
    Decensi, A
    Omodei, U
    Robertson, C
    Bonanni, B
    Guerrieri-Gonzaga, A
    Ramazzotto, F
    Johansson, H
    Mora, S
    Sandri, MT
    Cazzaniga, M
    Franchi, M
    Pecorelli, S
    CIRCULATION, 2002, 106 (10) : 1224 - 1228
  • [49] Effect of the Novel Selective Progesterone Receptor Modulator Vilaprisan on Ovarian Activity in Healthy Women
    Schuett, Barbara
    Schultze-Mosgau, Marcus-Hillert
    Draeger, Corinna
    Chang, Xinying
    Loewen, Stephanie
    Kaiser, Andreas
    Rohde, Beate
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (02): : 228 - 239
  • [50] Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women
    Nikander, E
    Metsä-Heikkilä, M
    Tiitinen, A
    Ylikorkala, O
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11): : 5180 - 5185
12345